Sentences with phrase «pharmaceutical industry and academia»

Not exact matches

This collection of Science Careers articles presents scenarios from both industry and academia — offering advice from advancing in one's academic career to preparing for a career in pharmaceuticals to investigating the benefits of a biotech training program.

Scientists in both academia and the pharmaceutical industry have tested marijuana derivatives and synthetic forms of the herb for potentially helpful chemical effects since the 1970s.

Since then, scientists in academia and the pharmaceutical industry have created thousands of pleuromutilin derivatives by a process known as semisynthesis, which involves chemically modifying pleuromutilin itself.

Such rearrangements are now a staple of organic chemists in both academia and industry for the production of everything from pharmaceuticals and agrochemicals to pheromones and polymers.

At one session, which covered research careers in industry and the private sector, Lawrence Fitzgerald, vice president of neuroscience research at Lundbeck Pharmaceuticals in New York City, said he had started to consider a job outside academia when he realized he cared more about the science than the setting.

Nevertheless, in light of the fierce competition and a slumping market for life sciences jobs in academia, biotechnology, and the pharmaceutical industry, it may be worth considering a career in the MD&D industry.

An international organisation which draws its membership from physicians, pharmacists, economists, nurses, and researchers from academia, pharmaceutical industry, government, managed care, health research organisations, and purchasers of health care.

The pharmaceutical industry, the National Institutes of Health, the FDA, academia, clinical research organizations and other key stakeholders will have the opportunity to focus on these disparities and identify the barriers and challenges in educating, recruiting and designing clinical trials.

Considerations about patenting and intellectual property exist in industry, although the same is true for academia these days, says Alan Goldhammer, vice president of scientific and regulatory affairs for Pharmaceutical Research and Manufacturers of America (PhRMA), an organization that represents the country's leading pharmaceutical research and biotech companies.

I am proud that my students are widely sought after for employment in academia and within the pharmaceutical and chemical industries.

This meeting provides a nexus for diagnostic developers in academia and industry as well as end - users in the pharmaceutical and healthcare sector to gain a comprehensive picture of molecular diagnostics in prenatal, oncology, infectious disease, point - of - care, and liquid biopsy.

These include life science industry representatives from pharmaceutical, medical devices and diagnostic industries, clinical innovators, hospital executives, payers, policy makers, multidisciplinary researchers, patient advocates, angel, venture capital investors and academia.

Really, though, the government needs to address the regulations which have burdened academia and the pharmaceutical industry.

Dr. Allison: CRI's Clinical Accelerator program has started to actually engage pharmaceutical companies that have these drugs, with the goal of bridging the divide between academia and industry.

Problems are primarily motivated by health care technologies of interest to pharmaceutical and biotechnological companies, and emphasize multi-disciplinary collaborative interactions, including colleagues in both academia and industry.

The all - day meeting showcased the work of more than 100 experts from academia, federal and regulatory agencies, government research agencies, pharmaceutical and biotech industry, and patient advocacy community who have worked together over the past several months to prepare draft consensus recommendations on how to address the regulatory issues around HIV cure research.

The author reveals how the food industry (dairy, meat), the big pharmaceuticals, and academia are in bed together and are behind the notion that you cite....

The vast majority of pharmacy graduates work as pharmacists in large retail chains or independent pharmacies but there are other job options available within academia, regulatory bodies and the pharmaceutical industry

The majority of pharmacy graduates become pharmacists; however they are also able to work within academia, regulatory bodies and the pharmaceutical industry.

PhD with documented success and experience in a diverse range of fields including academia, pharmaceuticals, and the medical device industry.